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Abstract: The measurement of circulating blood volume (CBV) is crucial in various medical 
conditions including surgery, iatrogenic problems, rapid fluid administration, transfusion of red blood 
cells, or trauma with extensive blood loss including battlefield injuries and other emergencies. 
Currently, available commercial techniques are invasive and time-consuming for trauma situations. 
Recently, we have proposed high-speed multi-wavelength photoacoustic/photothermal (PA/PT) flow 
cytometry for in vivo CBV assessment with multiple dyes as PA contrast agents (labels). As the first 
step, we have characterized the capability of this technique to monitor the clearance of three dyes 
(indocyanine green, methylene blue, and trypan blue) in an animal model. However, there are strong 
demands on improvements in PA/PT flow cytometry. As additional verification of our 
proof-of-concept of this technique, we performed optical photometric CBV measurements in vitro. 
Three label dyes—methylene blue, crystal violet and, partially, brilliant green—were selected for 
simultaneous photometric determination of the components of their two-dye mixtures in the 
circulating blood in vitro without any extra data (like hemoglobin absorption) known a priori. The 
tests of single dyes and their mixtures in a flow system simulating a blood transfusion system 
showed a negligible difference between the sensitivities of the determination of these dyes under 
batch and flow conditions. For individual dyes, the limits of detection of 3×10–6 M ‒ 3×10–6 M in 
blood were achieved, which provided their continuous determination at a level of 10–5 M for the 
CBV assessment without a priori data on the matrix. The CBV assessment with errors no higher than 
4% were obtained, and the possibility to apply the developed procedure for optical photometric (flow 
cytometry) with laser sources was shown. 
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1. Introduction 
Accurate and rapid assessment of circulating 
blood volume (CBV) is required in many clinical 
applications like evaluation of outpatients and 
inpatients experiencing extensive blood loss [1], 
rapid fluid administration, and transfusion of packed 
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red blood cells (RBC) [2]; estimation of 
haemodilution during surgery requiring 
cardiopulmonary bypass without blood transfusion 
[3, 4]; monitoring total blood loss during surgery or 
blood filtration during, e.g. haemodialysis [5]; 
ascertainment of RBC mass at baseline 
preoperatively and changing in response to 
erythropoietic therapies [6‒9], and estimation of the 
requirements of cardiac-assist devices [10]. 
However, existing techniques and assays require 
some improvements. Limitations include 
inaccuracies, high labour requirements, and slow 
cycle times for initial and repeat measurements.  
The mostly used methods for CBV assessment 
use optical photometric [11 15]‒ , fluorescence [16, 
17], or isotopic [18, 19] monitoring of dilution 
curves for contrast labels (dyes, tags, or markers) 
injected into an unknown blood volume. In 
photometric CBV assessment, a label dye (the most 
widespread is Evans blue [11]) is injected into a 
bloodstream and attaches itself to albumin [12] or in 
plasma [13, 14] or serum [20] with predetermined 
haematocrit (Ht) value [15]. The dye concentration 
in the bloodstream diminishes due to dilution in the 
whole blood volume. Its average concentration is 
measured with an optical photometer as a change in 
the absorbance at a certain wavelength. Assays using 
fluorescence-labeled albumins or radio-iodinated 
serum albumins are based on the above-mentioned 
label-dilution principle, but the dilution curve is 
measured as a fluorescence signal [16] or 131I 
pre-tagged to albumin [21, 22]. These assays cannot 
be used for a rapid CBV assessment without a priori 
data on haemoglobin (Hb) concentration and are 
insensitive. Isotopic dilution methods are also not 
reproducible [12, 23]. Tagged transfusion methods 
like 51Cr tagging of RBCs require a donor blood 
infusion [19]. In current practice, most clinicians 
agree that the transfusion of donor blood should be 
avoided unless necessary, thus making tagged 
transfusion methods less practical. Nowadays, 
clinical CBV assessment is implemented as in vivo 
pulse dye densitometry (PDD) [3, 4, 24 28]‒ . This 
method is based on the principles of pulse oximetry 
and label-dilution techniques at the absorption 
maximum of indocyanine green (ICG) dye [24, 
29 33]‒ . PDD provides a rapid (every 20 min–30 min, 
after the ICG from the previous injection is safely 
cleared by the liver [5]), semi-non-invasive, and 
convenient bedside CBV assessment [28, 34, 35] 
and is used for diagnostics [3, 4, 36 39]‒  and 
treatment of blood losses [30, 40, 41]. PDD 
correlates well with 131I or 51Cr [5, 42, 43] and 
satisfactorily with other methods [3, 4]. The 
haemoglobin concentration is measured from a 
pre-sampled blood before an ICG injection to 
establish the baseline absorbance for the current 
patient, otherwise PDD accuracy is degraded 
significantly. PDD also experiences several clinical 
problems: (1) it is barely suitable in many liver 
diseases and low cardiac outputs [38, 44]; (2) signal 
amplitudes of optical detection are low [3]; (3) the 
impact of PDD on the mortality and morbidity of the 
critically ill patients is still under verification [28]. 
Thus, existing assays provide a clinical 
justification and examples of CBV assessment; 
however, no single method is feasible and reliable 
enough to be widely applied. Label dilution using 
radioisotopes or dyes is unsuitable for clinical 
applications, as they do not allow for frequent 
repeated measurements and require high 
concentrations of labeled proteins or contrast agents. 
The state-of-the-art method is PDD, and the use of 
ICG holds promise as the least invasive technique 
for measurement. However, the sensitivity and 
precision are not sufficient, and a priori data on Hb 
concentration for each patient from an independent 
method are required.  
We have proposed high-speed multi-wavelength 
photoacoustic/photothermal (PA/PT) flow cytometry 
(PAFC/PTFC) [45‒47] for in vivo CBV assessment 
with multiple dyes as PA and PT contrast labels [48]. 
PA and PT techniques are based on direct 
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measurements of absorbed energy through its 
non-radiative transformation into thermal effects 
[49 55]‒ . Thermal changes in optical and acoustic 
properties of a sample upon the absorption of laser 
radiation allows detecting absorbances of 10–10 abs ‒ 
10–6 abs. units, concentrations of 10–11 M [56] and to 
analyze volumes of 10–12 L with as low as several 
absorbing molecules, including biotissues and 
nanoparticles [50, 51, 54, 57 63]‒ . We have 
characterized the capability of PAFC/PTFC to 
monitor the clearance of several dyes (ICG, 
methylene blue, and trypan blue) in an animal model 
in vivo and in real time [48]. Strong dynamic PA 
signal fluctuations were observed, which were 
associated with interactions of the dyes with 
circulating blood cells and plasma proteins [48]. 
PAFC demonstrated enumeration of circulating red 
and white blood cells labeled with ICG and 
methylene blue, respectively, and the detection of 
rare dead cells uptaking trypan blue directly in a 
bloodstream [48]. PAFC/PTFC offer advanced 
alternatives to PDD and other CBV assays as they 
provide much higher sensitivity of direct 
measurements of absorbed energy compared with 
light attenuation (as in absorption spectroscopy) or 
re-emitted light (fluorescent techniques) [49, 64‒68]. 
The PA technique with natural chromophores (Hb or 
melanin) or lowly toxic nanoparticles as PA contrast 
agents is currently the fastest-growing area of 
biomedical imaging, providing higher sensitivity 
and resolution at a single-cell level in deeper tissues 
(up to 3 cm ‒ 5 cm) compared with other optical 
modalities [50, 51, 55, 63, 64]. These techniques 
offer the highest absorption sensitivity (100-fold ‒ 
1000-fold better than PDD/absorption spectroscopy), 
which allows for noninvasive detection of unlabeled 
biomolecules at a threshold comparable with that of 
fluorescence labeling (which is toxic for humans) 
[54, 69]. Methods are safe; the short-term 
temperature rise of less than or equal to 0.01 C ‒    
1 C at low laser fluences (5 mJ/cm2 ‒ 20 mJ/cm2) is 
well within the laser safety standard of 35 mJ/cm2 ‒ 
100 mJ/cm2 at 650 nm ‒ 1100 nm [55, 70]. The 
tremendous clinical potential and safety of PA/PT in 
vivo have been demonstrated in many clinical trials 
of other applications [64]. Examples include 
imaging of breast tumours at centimetre-scale depths 
[61, 62] or blood microvessels [55], continuous 
monitoring of blood oxygenation in 
15-mm-diameter jugular veins despite light 
scattering in a 15-mm ‒ 20-mm-thick layer of 
overlying tissue [71], and measurement of blood 
[Hb] [58]. PT determination of various Hb species 
(desoxyhaemoglobin, oxyhaemoglobin, 
carboxyhaemoglobin, methaemoglobin, 
cyanohaemoglobin, and hemichrome) with the limits 
of detection of 10–8 M was made [72]. The error of 
determination of desoxyhaemoglobin vs. 
oxyhaemoglobin and vice versa was not above 3% ‒ 
5% for the ratio of the species of 10:1 [72]. Recently, 
PAFC has been developed for in vivo detection of 
circulating tumour cells and bacteria targeted by 
nanoparticles. As a whole, rapid PA/PT tests can be 
implemented as the determination of several dyes 
introduced in the blood as the difference in their 
absorption spectra can be used for the determination 
of their dilution. However, there are still strong 
demands on improvements of PAFC/PTFC. 
As an additional step in the verification of the 
PAFC/PTFC as a CBV assessment platform [48], we 
focused on photometric CBV assessment with 
several dyes in vitro. Several clinically relevant 
absorbing dyes were tested in the presence and 
absence of blood to select optimum dye/wavelength 
combination for the simultaneous determination of 
components of their two-dye mixtures in blood 
under the conditions of CBV assessment.  
2. Experiments 
2.1 Reagents, solvents, and solutions 
The following dyes were used: methylene blue 
(MB, CAS no. 61-73-4), brilliant green (BG, CAS 
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no. 633-03-4), crystal violet (CV, CAS no. 
548-62-9), indigo carmine (CAS no. 860-22-0), 
bromsulphalein (CAS no. 71-67-0), and Evans blue 
(CAS no. 314-13-6); their stock solutions of 0.10% 
wt. in PBS (20 mM, pH 7.4) were used throughout. 
Other reagents were high-purity 0.1 M KOH, conc. 
cp HNO3, and p.a. acetone. Water from a TW- 
600RU water purification system (Nomura 
MicroScience Co., Ltd.; Okada, Atsugi-City, 
Kanagawa, Japan) was used: pH 6.8; specific 
resistance 18.2 Mcm, Fe, 2 ppt; dissolved SiO2,  
3 ppb; total ion amount, <0.2 ppb; TOC, <10 ppb. 
Solutions were made using a Branson 1510 
ultrasonic bath (USA), power 1 W (exposure times 
10 min ‒ 15 min). The glassware was washed with 
acetone followed by conc. nitric acid. The blood of 
rats stabilized with heparin was used at the stages of 
blood batch and flow tests. 
2.2 Flow manifold for in vitro measurements 
The flow manifold (Fig. 1) consists of a circular 
flow system pumped with a Watson–Marlow 501U 
peristaltic pump (UK), a cylindrical flow cell (l = 
15 mm; 16 cm3), and a changeable (volume-adjusting) 
vessel (volume, 0.25 L to 6 L). All the tubing parts 
are from a KDM blood-transfusion system (KD 
Medical GmbH, Germany; length 90 cm, i.d. 0.3 cm). 
The system is filled with doubly distilled water, PBS, 
or stabilized rat blood. The dye is injected through a 
valve before the measurement cell to emulate the 
injection of the target dye in in vivo tests. The flow 
rate is kept at (35±1) mL/min (linear velocity 2 cm/s). 
After each measurement, the working liquid is 
drained to waste and washed with distilled water 
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Fig. 1 Flow manifold for circulating blood volume 
estimation using flow photometry. 
2.3 Measurements 
A laser-based setup on the basis of a previously 
described continuous-wave (CW) mode PT-lens 
spectrometer was used [73]. The schematic (Fig. 2) 
was based on recording an induced refractive-index 
heterogeneity (thermal-lens effect, excitation: 
(IDLS5 diode lasers, Polyus, Moscow; wavelengths 
532 nm, 610 nm, 635 nm, 660 nm, and 690 nm; waist 
diameter, 59.8 m  0.5 m; power range 1 mW ‒   
20 mW) causing defocusing of a collinear probe 
beam (diode laser, wavelength, 808 nm; waist 
diameter, 25.0 m ± 0.2 m; (attenuated) power,    
1 mW) and, hence, a reduction in the probe beam 
intensity at its center by a far-field photodiode 
(sample-to-detector distance 180 cm) supplied with a 
stained-glass broadband-range (610 nm ‒ 640 nm) 
bandpass filter and a 2-mm-diameter pinhole    
(Fig. 2).  
The synchronization of the measurements was 
implemented by in-house written software. The PT 
spectrometer has a linear dynamic range of the 
signal of four orders of magnitude (the range of 
absorption coefficients for 10 mm optical pathways 
is 110–6 cm1 to 210–2 cm1) and the response time 
of 0.005 s – 2 s (depending on the selected 
measurement parameters, namely, on the data 
throughput rate and time, the number of points to be 
averaged, etc.). The spectrometer implements a 
secondary channel (for gathering the scattering 
signal, if present). The probe beam was reflected by 
a dichroic mirror; the residual excitation beam was 
removed with a stained-glass bandpass filter and 
after a 2-mm pinhole appeared at the primary PT 
detector. If the photometric or PT channel was not 
needed, the corresponding detector was switched 
off. 
Spectrophotometric measurements in a batch and 
flow modes were made using an Agilent Cary 60 
spectrophotometer (USA) with l=1 mm, 0.3 cm3. The 
pH values were measured by an inoLab pH Level 1 
pH-meter (Germany) with a glass pH-selective 
electrode (precision 5%). Solutions were mixed 
with a Biosan MMS 3000 automixer and a 
micro-stirrer. 
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Fig. 2 Schematics of the dual-beam flow photometer / thermal-lens spectrometer. 
2.4 CBV assessment 
We used dyes for intravenous administration for 
optical absorbance determination of single dyes or 
components of two-dye mixtures in circulating 
blood. CBV was measured as an average of two 
signals for each dye to decrease the interference of 
both dyes on one another and thus to improve the 
accuracy (and determined after their dilution in 
circulation). The concentration of each dye 
diminished due to dilution. From a curve of the 
relative decrease in the concentration, CBV was 
calculated from the ratio of concentrations of the 
initial dye solution and the solution of dye in the 
blood according to the following [2, 5, 15, 74]:  
CBV =V0A0/Ax = V0c0/cx          (1) 
where A is absorbance, V0 and c0 are initial volume 
and concentration of the dye solution, and cx is the 
dye concentration in the blood after its dilution   
(Fig. 3). The determination of two components a and 
b of a dual-component mixture was made using two 
methods (1) a standard Vierordt’s method at two 
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and (2) using an overdetermined Vierordt’s system 
at four wavelengths to decrease the overall error 
[48]: 
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Fig. 3 Dilution curve of a dye (methylene blue) in CBV 
measurements. 
Here, A is absorbance acquired from 
spectrophotometric measurements. Maxima 
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1 1 1 1 ( )b a a b f
          were used as the 
wavelengths for Vierordt’s method. For the 
overdetermined Vierordt’s system, (3), 1 and 3 are 
at the maxima, and λ2 and 4 are at the minima of the 
absorption spectra of a and b components. The 
calculations of dye concentration were made taking 
into account the condition сa/сb=const, which is 
correct for preliminarily prepared two-dye mixtures 
injected into a flow [48]. 
2.5 Procedures 
2.5.1 Tests of the flow manifold 
For each dye, the solutions with a concentration 
of 0.01% wt ‒ 0.1% wt. were prepared, and the 
solution volume varied as 250.0 mL, 500.0 mL, 
1000.0 mL, 2000.0 mL, 4000.0 mL, or 6000.0 mL. 
The solutions were placed in a vessel connected to 
the flow manifold and the photometric signals were 
measured at a flow rate of 35 mL/min (velocity,    
2 cm/s). Next, aliquots (20 mL) were probed and 
measured at batch conditions. Standard deviation 
and RSD for the same concentration and the same 
dye were measured for batch and flow conditions.  
2.5.2 Spectrophotometric determination of label 
dyes in the flow 
The 250-mL vessel of the flow manifold was 
filled with distilled water, which started to circulate 
continuously through the manifold and the flow cell. 
After zeroing the absorbance, an aliquot (0.2 mL) of 
the working solution of the dye was injected and the 
absorbance was continuously measured, at the 
working wavelength (663 nm, 624 nm, and 590 nm 
for MB, BG, and CV, respectively) until the constant 
value was attained. Next, another aliquot was 
injected into the same solution. The manifold was 
washed with 0.5 L of distilled water after 
measurements. 
2.5.3 Differential photometric determination of 
label dyes in the flow 
The 250-mL vessel of the flow manifold was 
filled with a solution of the dye with absorbance of 
A=1.0 ‒ 2.0 (2.00 mL ‒ 3.50 mL of the stock solution 
was diluted to 250 mL) at the working wavelength 
(663 nm, 624 nm, and 590 nm for MB, BG, and CV, 
respectively). Next, the actions were similar to 
Procedure 2.5.2. 
2.5.4 Absorption spectra of label dyes in blood 
Dye solutions in blood were prepared in 
photometric cells: 0.02 mL of the stock solution of 
the dye and 0.40 mL of blood were placed in a cell 
and mixed with a micro-stirrer followed by the 
determination of absorption spectra. 
2.5.5 In vitro determination of label dyes under 
batch conditions 
Stock solutions of selected dyes in blood   
(0.40 mL of the stock solution of the corresponding 
dye and 0.60 mL of blood) were used. This freshly 
prepared stock solution was diluted in the 
photometric cells alike in Procedure 2.5.4 by adding 
a 0.01 mL ‒ 0.05 mL of this solution to 0.40 mL of 
blood. The calibrations were made at wavelengths 
615 nm, 630 nm, 663 nm, and 690 nm, and the limits 
of detection and other performance parameters were 
calculated. 
2.5.6 In vitro assessment of circulating blood 
volume  
The main glass vessel of the manifold was filled 
with the precisely measured blood volume, and the 
blood started circulating through the manifold. 
When the regular flow through the cell was 
established, the zero absorbance was calibrated. 
Next, 0.4 mL of an aliquot of stock solutions of MB 
and CV or their mixture was injected, and the 
absorbances at 615 nm, 630 nm, 663 nm, and 690 nm 
were recorded until constant absorbance values were 
reached. The concentrations of both labels were 
determined from (3). 
2.5.7 Photometric assessment of circulating 
blood volume in a model system  
The main glass vessel of the manifold (Fig. 1) 
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was filled with the precisely measured blood volume, 
and the blood started circulating through the 
manifold. When the regular flow through the cell 
was established, the zero absorbance was calibrated. 
Next, 0.4 mL of a mixture of stock solutions of MB 
and CV was injected, and the absorbances at 615 nm, 
630 nm, 663 nm, and 690 nm were recorded until 
constant absorbance values were reached. The 
concentrations of both labels were determined from 
(3). 
3. Results and discussion 
3.1 Initial label dye tests 
Multiple absorbing dyes including MB, BG, CV, 
congo red, indigo carmine, Evans blue, and 
bromsulphalein (most previously tested on humans) 
[25, 77 ‒ 82] were tested in the presence and absence 
of blood to select the optimal clinically relevant dye 
and the wavelength combination with minimal 
overlapping spectral effects, low concentration (i.e. 
minimum toxicity), and required accuracy.  
As the aim was to develop a system for rapid 
analysis with trace labels, we excluded indigo 
carmine, bromsulphalein, and Evans blue as the 
sensitivity of their spectrophotometric determination 
was low and CBV assessment would require their 
high concentrations. Also we excluded ICG and 
trypan blue, which were previously successfully 
tested with PAFC to expand the usable label 
selection [48]. 
The absorption spectra of the remaining labels 
show rather significant absorbance over blood 
background (Fig. 4) and do not change in the pH 
range 6.0–8.0 characteristic to blood.  
Spectrophotometric determination of MB, CV, 
and BG in aqueous solutions (Procedure 2.5.2) 
results in limits of detection of 110–7 М. 
Differential determination of these label dyes against 
backgrounds of 0.5 ‒ 2.0 absorbance units showed a 
decrease in the sensitivity by an order, which can be 





Fig. 4 Absorption spectra of blood and selected dyes in 
blood (a) absolute and (b) differential; crystal violet (CV, 
1.210–4 М), Brilliant Green (BG, 9.810–5 М), and methylene 
blue (MB, 1.310–4 М); l = 1 cm. 
Table 1 Differential spectrophotometric determination of 
contrast dyes, pH 7.5, n = 5, and P = 0.95. 
Dye (max) Abkgr cmin  (×107 M) 
Lin. calib. 
range (×106 M) r 
0.78 1 1 19‒  0.9961 
0.90 1 4 25‒  0.9933 
1.25 1 5 36‒  0.9721 
1.44 2 7–60 0.9687 
1.91 2 20 150‒  0.9383 
MB   
(663 nm) 
2.17 20 50‒500 0.9561 
0.54 1 1–25 0.9965 
0.73 1 1–28 0.9886 
1.04 1 6–42 0.9819 
1.33 2 5–50 0.9696 
1.71 10 30–200 0.9042 
BG   
(624 nm) 
1.88 20 40–500 0.8826 
0.75 1 4–28 0.9716 
1.07 1 7–38 0.9667 
1.43 2 7–77 0.9511 
1.66 3 10–120 0.8922 
1.91 10 20–160 0.9677 
CV   
(590 nm) 
1.98 10 20–230 0.9637 
 
As absorbance spectra of any dual mixtures of 
selected dyes overlap, Vierordt’s method should be 
used for data treatment. The comparison of variants 
of Vierordt’s methods showed that the best results 
were obtained when the ratio of molar 
concentrations for both labels was constant during 
all the tests.  
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According to our previous findings, a two- 
wavelength Vierordt’s system provided the error of 
20% for micromolar concentrations of both dyes in a 
two-dye mixture; however, the use of a four- 
wavelength overdetermined system decreases the 
error to 7% [48].  
The results for the selected dyes (Tables 2, 3, 
and 4) confirmed this: a two-wavelength system 
resulted in 6% ‒ 15% of errors in the determination 
of the concentration and, as a result, CBV provided 
a significant increase in the precision (replicability). 
In this case, the limits of detection of all the three 
dyes differ insignificantly from single dye solutions. 
The flow spectrophotometric determination of 
individual labels in the transfusion manifold 
(Procedure 2.5.3) showed negligible difference from 
the batch conditions.  
Table 2 Comparison of results of determination of 
components of two-dye mixtures of MB and BG at pH 7.5, n=3, 
and P=0.95. [cadd is added concentration, ccalc is a concentration 
found from (3) (concentrations in M)]. 
ccalc 
cadd 
663+690+624+550 (nm) 663 + 624 (nm) 
MB 
4.3 4.4 ± 0.4 (3.6%) 4.4 ± 0.3 (3.8%) 
6.4 6.3 ± 0.5 (5.5%) 6.2 ± 0.4 (2.7%) 
8.6 8.8 ± 0.4 (3.0%) 8.8 ± 0.3 (2.5%) 
11 10 ± 1 (5.8%) 10 ± 1 (6.1%) 
13 12 ± 1 (5.0%) 12 ± 1 (5.0%) 
BG 
3.3 3.5 ± 0.3 (5.0%) 3.4 ± 0.4 (3.3%) 
5.0 5.2 ± 0.2 (3.6%) 5.2 ± 0.3 (3.6%) 
6.6 6.6 ± 0.1 (0.1%) 6.7 ± 0.2 (0.6%) 
8.3 8.3 ± 0.3 (2.6%) 8.1 ± 0.3 (2.2%) 
10 9.3 ± 0.4 (6.2%) 9.5 ± 0.5 (4.8%) 
Table 3 Comparison of results of determination of 
components of two-dye mixtures of MB and CV at pH 7.5, n=3, 
and P=0.95. [cadd is added concentration, ccalc is a concentration 
found from (3) (concentrations in M)]. 
ccalc 
cadd 
663+690+630+590 (nm) 663+590 (nm) 
MB 
4.3 4.6 ± 0.3 (6.3%) 4.1 ± 0.3 (4.1%) 
6.4 6.3 ± 0.4 (2.1%) 4.2 ± 0.2 (2.7%) 
8.6 8.9 ± 0.4 (3.5%) 8.1 ± 0.4 (6.0%) 
11 10 ± 1 (2.0%) 10 ± 1 (9.1%) 
13 12 ± 1 (4.1%) 12 ± 1 (6.4%) 
CV 
3.9 4.2 ± 0.3 (7.0%) 4.5 ± 0.3 (15.2%) 
5.9 6.2 ± 0.3 (6.3%) 6.3 ± 0.3 (6.8%) 
7.8 6.6 ± 0.3 (4.3%) 8.8 ± 0.7 (12.6%) 
10 9.8 ± 0.4 (0.3%) 10 ± 1 (6.8%) 
12 12 ± 1 (1.5%) 12 ± 1 (5.0%) 
For two-dye mixtures, the relative standard 
deviation of the determination is below 10% and is 
2% ‒ 5% for micromolar dye concentrations while 
using four-wavelength determination with an 
overdetermined Vierordt’s system of equations. 
The model flow manifold emulated a transfusion 
system: a 0.3 cm i.d, and the flow rate of 35 mL/min; 
the flow cell had the same diameter. The changes in 
the circulating blood volume within the range   
250 mL ‒ 6000 mL (Procedure 2.5.1) showed that the 
absorbance levels, the reproducibility, and accuracy 
of measurements for haemoglobin and all the dyes 
did not depend on the volume. CV and MB showed 
negligible absorption on the materials of the 
transfusion system, while BG was intensively 
absorbed by the manifold. 
Table 4 Comparison of results of determination of 
components of two-dye mixtures of CV and BG at pH 7.5, n=3, 
and P=0.95. [cadd is added concentration, ccalc is a concentration 
found from (3) (concentrations in M)]. 
ccalc 
cadd 
630+590+624+550 (nm) 624+590 (nm) 
BG 
3.3 3.4 ± 0.3 (2.4%) 4.0 ± 0.6 (19.9%) 
5.0 5.0 ± 0.1 (0.1%) 5.6 ± 0.5 (12.8%) 
6.6 6.6 ± 0.1 (0.04%) 7.8 ± 0.4 (16.9%) 
8.3 8.2 ± 0.2 (1.7%) 8.8 ± 0.3 (6.8%) 
10 10.0 ± 0.3 (0.02%) 10 ± 1 (5.2%) 
CV 
3.9 4.1 ± 0.3 (4.7%) 3.4 ± 0.3 (12.8%) 
5.9 5.8 ± 0.4 (2.2%) 5.1 ± 0.6 (12.7%) 
7.8 8.0 ± 0.2 (2.3%) 6.6 ± 0.5 (15.9%) 
10 10 ± 1 (2.2%) 8.2 ± 0.4 (15.9%) 
12 11 ± 1 (4.7%) 10 ± 1 (13.6%) 
3.2 Assessment of dyes in blood 
Brilliant green shows a very indistinct spectrum 
in the target wavelength range (600 nm ‒ 650 nm) in 
blood, while MB and CV show very good 
differential spectra in 630 nm ‒ 680 nm and      
610 nm ‒ 690 nm, respectively (Procedure 2.5.4). No 
correlation with their concentrations over 690 nm is 
due to haemoglobin absorption. The limits of 
detection of dyes in blood (Procedure 2.5.5) are 
3×10–6 M ‒ 8×10–6 M (Table 5); the error of 
determination is low, providing assessing both dyes 
in blood with relative standard deviations below 5% 
at 10–5 M. 
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Table 5 Performance parameters for the assessment of 
contrast dyes in blood, n=5 and P=0.95.  
Dye λ (nm) cmin (×106 М) 
Lin.cal. range 
(×105 M) r 
690 20 0.7830 
680 10 0.9381 
663 10 0.9694 
630 10 0.9822 
630 + 690 10 0.9896 
630 + 680 10 0.9786 
630 + 663 10 0.9268 
663 + 690 20 0.7435 
MB 
663 + 680 40 
4‒20 
0.7648 
630 5 0.9934 
615 3 0.9569 
615 + 690 2 0.9766 
615 + 663 2 0.9726 
630 + 690 3 0.9897 
CV 




Varying the wavelengths of Vierordt’s system, 
we selected the optimum wavelengths for the 
overdetermined system, 630 nm and 690 nm for MB 
and 615 nm and 663 nm for CV (Procedure 2.5.5). 
For blood volumes 0.3 L ‒ 6 L, the error of 
assessment was below 4%. 
The optimum wavelengths fit the wavelengths of 
serial diode lasers, which can be used in compact 
detection schematics for photometric CBV 
assessment. We tested such a system with 
commercial diode lasers with 610 nm, 635 nm,   
660 nm, and 690 nm. The error of measurements 
increased to 10%, which can be considered a 
satisfactory result. 
3.3 Laser-based measurements of dyes in blood 
The above values were confirmed using the 
developed laser-based flow spectrometer tested in 
vitro in batch and flow conditions using the 
available flow module as a simple model for a blood 
vessel and an absorption spectroscopy unit to 
real-time measure of absorption spectra of dye alone 
and in mixtures.  
The setup (Fig. 2) was built using the previously 
optimized schematics taking into account the 
precision of measurements and the linear range of 
the thermal lens signal. The main idea is to combine 
photometric and PA/PT measurements in a single 
setup. This idea was supported by our previous data 
on the use of the thermal-lens spectrometer as a 
single-wavelength photometer providing enough 
measurement precision [73]. The probe wavelength 
of 808 nm (marked grey in Fig. 2) was selected as it 
provided the minimum light absorption of the blood 
components and selected dyes and low scattering. 
The excitation beam was made of four beams of 
diode lasers with the same beam parameters and the 
wavelengths of 610 nm, 635 nm, 660 nm, and 690 nm. 
In a more advanced mode, the diode laser with the 
same beam parameters and the wavelength of   
532 nm was added. The lasers were chopped in 
sequence synchronized with the main light chopper 
at a frequency of ; thus, every excitation on-off 
cycle of the thermal lens corresponded to the certain 
wavelength, and the frequency of the excitation with 
the same wavelength was /4 (or /5 for a 
five-wavelength mode). 
In order to get the maximum information for a 
flowing sample (at a flow rate of 35 mL/min), high 
chopper frequencies are preferable, while the 
sensitivity of PT measurements decrease with the 
chopper frequency [83]. Thus, a compromise 
frequency of 10 Hz was used, which corresponded to 
2.5 Hz frequency for a single wavelength. This 
corresponded to the measurement of ca. 0.15 mL of 
the flowing sample with a certain wavelength and 
0.45 mL with other wavelengths, in cycles.  
To implement dual-mode measurements, we 
used a dichroic mirror to separate the probe beam 
from the excitation. The whole excitation beam after 
the cell penetrated the dichroic mirror and was 
gathered with a focusing lens by the primary 
photometric detector, which was compared with 
pre-calibrated power meter used as the absorbance 
ground signal. The selection of the optimum 
parameters of PT measurements were discussed 
previously [73, 84].  
The results obtained using laser-based 
photometry at the selected wavelengths were in 
good agreement with the performance parameters in 
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Table 5. The estimations of CBV in the test manifold 
similarly to Procedure 2.5.1 showed the error of 
assessment is below 5% for blood volumes 0.3 L ‒  
5 L and above concentrations of dyes diminished 
compared with photometric measurements. The 
error of measurements agrees well with our previous 
data on PAFC measurements of CBV [48]. 
4. Conclusions 
As an additional verification of our proof- 
of-concept of the PAFC [48, 68, 85‒90] for CBV 
assessment, we performed optical photometric CBV 
measurements in vitro with a specially designed 
multi-wavelength photothermal-lens spectrometer 
and a procedure for photometric determination of 
two dyes (methylene blue and crystal violet) in a 
blood-transfusion system. The precision of 
measurements is somewhat worse than in PDD [3, 
24, 25], but better than photometric measurements 
[13‒15, 20] and does not require any a priori data on 
the test system and is simple and inexpensive. Tests 
of single dyes and their mixtures in a flow system 
simulating a blood transfusion system showed 
micromolar limits of detection in blood with low 
errors. These data complements our previous 
findings for in vivo PAFC [48]. 
Moreover, one can see a decrease in the error of 
measurements by a factor of 3 ‒ 4 compared with 
existing CBV techniques due to the independent 
determination of two dyes instead of one at two 
different wavelengths. The measurement provides a 
decrease in the contrast agent concentrations by a 
factor of at least 30 due to the high absorption 
sensitivity of PA/PT spectroscopy and low influence 
of scattering effects [91]. Moreover, we expect a 
decrease in the error of measurements by a factor of 
3 ‒ 4 compared with existing CBV techniques due to 
the independent determination of two dyes instead 
of one at two different wavelengths [48]. The 
determination of Hb [72] simultaneously with dye 
dilution will provide lower measurement time (2 ‒ 4 
fold) compared with photometric CBV techniques 
and PDD [73]. If the determination of selected dyes 
against high blood backgrounds (1 cm1 ‒ 10 cm1) 
[55] shows a decrease in the sensitivity by more than 
an order of magnitude compared with the buffer 
solution, the differential PT schematics can be used 
in the future, which previously showed a significant 
accuracy (3% vs. 5% under the same conditions) and 
sensitivity (2 orders compared with non-differential 
schematics) [92, 93]. When necessary, we can 
increase the number of dyes to 3 or 4 in the mixture 
to additionally improve the accuracy of CBV 
measurements. 
It is possible to compare the sensitivities of 
photometric and PT measurements for the same 
detector and the same laser used for measuring 
absorption and PT excitation. The minimum 
detectable linear absorption coefficients for PT and 
photometric (PM) measurements were calculated 
according to the equations previously deduced from 
the theory of these two methods for the conditions of 
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(5) 
where h is the Planck constant, e and p are 
frequencies of the excitation and probe beams;  is 
the detector quantum yield; f is the detection 
channel bandwidth; 0 is the excitation beam radius; 
 is the chopper frequency in PT measurements; Pe 
and Pp are the excitation and probe powers, DT is the 
thermal diffusivity, 0e is the excitation beam waist 
radius, and B∞ is the steady-state geometry constant 
of the setup optical scheme. The factor E0 is the 
enhancement factor of PT measurements for unit 
excitation laser power 
 0 pE dn dT k            (6) 
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where k is the thermal conductivity. The comparison 
of sensitivities for the same detector type [ and f 
parameters in (4) and (5)] and the same source of 
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(7) 
This shows that an increase in the sensitivity 
depends on the geometry parameters of the setup 
and the parameters of the medium, in which the 
thermal lens is bloomed. For the experimental 
conditions discussed above the calculation shows 
that the minimum detectable linear absorption 
coefficient is about 250-fold lower that for 
photometry. This means that the significant 
diminishing of dye doses to get reliable PT signals 
compared with current clinical doses (for PDD,    
2.5 mg/mL ‒ 5 mg/mL) can be made when shifting 
from optical photometric to PT measurements of 
CBV. 
We anticipate that this non-invasive rapid 
real-time CBV assessment is valuable for 
monitoring surgical patients in the operating room, 
especially those undergoing surgery with predictable 
substantial blood loss. The high capacity of a 
multi-wavelength PTFC technique would provide 
CBV assessment with expected advantages 
compared with existing assays. Successful 
completion of these specific aims will provide a 
novel method for CBV measurements in vivo and 
will shift clinical paradigms by achieving high 
sensitivity (50-fold ‒ 100-fold higher than that using 
existing techniques), rapid turnaround (a few 
minutes vs. hours due to exclusion of any a priori 
information on the patient), and high accuracy (4% ‒ 
7% vs. 15% ‒ 30%). The proposed platform can be 
further applied to PA or PAFC measurements of 
multiple blood parameters including a total Hb 
amount, Ht, oxygenation, abnormal blood cells (e.g., 
sickle), and Hb composition e.g., meta-, carboxy-, 
nitroso- or HbS (e.g., in sickle cells) during various 
diseases like anaemia as well as on use of 
encapsulated dyes (e.g. ICG). This system can be 
also used along with optical-fiber sensors [95]. After 
proof-of-concept on a small animal model, we will 
plan a preclinical validation with a lager animal 
model (e.g., sheep), eventually clinical validation, 
and feasibility testing (e.g., evaluation of 
measurement sites including finger, nose, lip, ear, 
and hand veins). 
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